BioSpace News Archive

Masimo (NASDAQ: MASI) today announced the findings of a Viewpoint article recently published in the Journal of the American Medical Association (JAMA) which highlighted the benefits of remote home patient monitoring, reporting in part on research that used Masimo SafetyNet®.

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), today announced that its executive leaders will be providing an overview of the Company’s gene therapies for cancer and diabetes to investors and industry professionals at the following investor and industry conferences in April 2022.

Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog semiconductors connecting people, places and things, will conduct a conference call with analysts to discuss its second quarter fiscal 2022 results and business outlook on May 3, 2022, at 4:30 p.m. EDT.

Heat Biologics, Inc. announced a planned development partnership of its Scorpion Biological Services subsidiary with a private developer, the State of Kansas and local and university affiliates, to support the development of a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas.

As researchers using genome editing tools move from basic research to clinical settings, high-quality ancillary materials and documentation are critical.

BENDIT Technologies, a company focused on the development of a steerable microcatheter platform, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcatheter for treatment in the neuro, peripheral, and coronary vasculature.

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2022 following the close of regular trading on Tuesday, May 3, 2022.

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, will provide a first look at data from its COVID-19 influenza combination vaccine and seasonal influenza vaccine trials, at the World Vaccine Congress (WVC) in Washington, DC, April 18 - 21, 2022.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the launch of the ReSolve® Thoracostomy Tray.

Revive Therapeutics Ltd. today announced the publication of a scientific article evaluating the impact of medication, including Bucillamine, on antibody response to SARS-CoV-2 mRNA vaccines in Japanese patients with rheumatic diseases.